This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Solazyme Reports Fourth Quarter And Full Year 2012 Results

In addition, please refer to the documents that Solazyme, Inc. files with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q, as updated from time to time, for a discussion of these and other risks. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release. Solazyme is not under any duty to update any of the information in this press release.

SOLAZYME, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
In thousands, except per share amounts
(UNAUDITED)
 

Three Months Ended December 31,

Twelve Months Ended December 31,

  2012     2011     2012     2011  
Revenues
Research and development programs $ 3,811 $ 8,251 $ 27,649 $ 26,793
Product revenues 4,613 1,638 16,459 7,173
License fees - 5,000 - 5,000
       
Total revenues 8,424 14,889 44,108 38,966
 
Costs and operating expenses (1)
Cost of product revenue 1,404 828 5,311 2,420
Research and development 16,108 16,921 66,384 45,613
Sales, general and administrative   15,888     12,835     57,516     41,426  
Total costs and operating expenses 33,400 30,584 129,211 89,459
       
Loss from operations (24,976 ) (15,695 ) (85,103 ) (50,493 )
 
Other income (expense)
Interest and other income (expense), net 249 114 1,511 229
Loss from equity method investment (631 ) - (1,824 ) -
Gain (loss) from change in fair value of warrant liability   748     -     2,284     (3,637 )
Total other income (expense) 366 114 1,971 (3,408 )
       
Net loss (24,610 ) (15,581 ) (83,132 ) (53,901 )
 
Accretion of redeemable convertible preferred stock   -     -     -     (60 )
 
Net loss attributable to Solazyme, Inc. common stockholders $ (24,610 ) $ (15,581 ) $ (83,132 ) $ (53,961 )
 

Net loss per share attributable to Solazyme, Inc. common stockholders, basic and diluted

$ (0.40 ) $ (0.26 ) $ (1.37 ) $ (1.35 )
 

Weighted average number of common shares used in loss per share computation, basic and diluted

60,873 59,703 60,509 39,934
SOLAZYME, INC.
RECONCILIATION OF GAAP TO NON-GAAP BASIC NET LOSS PER SHARE
In thousands, except per share amounts
(UNAUDITED)
         

Three Months Ended December 31,

Twelve Months Ended December 31,

  2012       2011     2012       2011  
Net loss attributable to Solazyme, Inc. common stockholders $ (24,610 ) $ (15,581 ) $ (83,132 ) $ (53,961 )
 
(Gain) loss from change in fair value of warrant liability (748 ) - (2,284 ) 3,637

(1) Operating expenses include stock-based compensation

expense as follows:

Research and development 985 846 3,924 2,413
Sales, general and administrative   2,859       2,502     11,478       8,510  
Total stock-based compensation expense 3,844 3,348 15,402 10,923

 

           

Net loss attributable to Solazyme, Inc.

common stockholders (non-GAAP)

$ (21,514 )   $ (12,233 ) $ (70,014 )   $ (39,401 )
 

Basic and diluted loss per share attributable to

Solazyme, Inc. common stockholders (GAAP)

$ (0.40 ) $ (0.26 ) $ (1.37 ) $ (1.35 )
 
(Gain) loss from change in fair value of warrant liability (0.01 ) - (0.04 ) 0.09
Stock-based compensation expense   0.06       0.06     0.25       0.27  
 

Net loss per share attributable to Solazyme, Inc.

common stockholders (non-GAAP)

$ (0.35 )   $ (0.20 ) $ (1.16 )   $ (0.99 )
SOLAZYME, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
In thousands
(UNAUDITED)
     
December 31, December 31,
  2012         2011
Assets
 
Current assets
Cash, cash equivalents and marketable securities $ 149,005 $ 243,724
Other current assets 16,274 15,169
         
Total current assets 165,279 258,893
 
Property, plant and equipment - net 32,225 25,985
Other assets 19,520 346
         
Total assets $ 217,024       $ 285,224
 
Liabilities and stockholders' equity
 
Current liabilities
Current portion of long-term debt $ 7,331 $ 5,289
Other current liabilities 17,607 23,923
         
Total current liabilities 24,938 29,212
 
Other liabilities 1,138 491
Long-term debt   7,637         14,963
Total liabilities   33,713         44,666
Total stockholders' equity 183,311 240,558
         
Total liabilities and stockholders' equity $ 217,024       $ 285,224




4 of 5

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,940.43 -42.16 -0.25%
S&P 500 1,972.74 -6.17 -0.31%
NASDAQ 4,448.7280 +3.8190 0.09%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs